|
|
 |
|
Viewing report
|
|
|
|
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
Takeda Pacific, July 2007, Pages: 131
This report assesses the RNA interference market for drug R&D. RNA interference (RNAi) has been hailed in the science media as the hottest technical breakthrough in bioscience in the last ten years. A 2006 Nobel Prize was awarded to the two scientists that discovered this important biological effect.
RNAi allows scientists to disrupt or silence the expression of a gene being studied. RNAi can also be used as a therapeutic agent. This field has quickly emerged as a fast growing young market. The report provides the WW outlook and market trends.
This must-have report discusses how an expanding number of companies have created a vibrant commercial market that has segmented into different areas of life science research and drug R&D. The market might be worth billions in a few years.
This study reviews the market landscape and analyzes the players. The market areas studied range from life science research products and services to therapeutics or drug delivery tools for RNAi agents.
The report discusses RNAi topics including dsRNA, shRNA, siRNA, ddRNA, miRNA, RNAi-as-drug, and targeted disease areas. This study analyzes RNAi deals including M&As, alliances and examples of patent considerations. For example, a number of big pharma companies are developing drugs with RNAi and have either licensed or partnered with RNAi R&D companies. One big pharma acquired a leading RNAi developer.
This report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. The report includes 39 detailed tables and figures that provide key data about items such as strategic alliances, M&As, market size, segments and so on.
Twenty company profiles provide the reader a snapshot of the companies’ focus or activities. This PDF formatted report is searchable by using key words. Internet links help readers access companies’ own web sites for further review.
Customers who bought this item also bought
RNAi 2008
RNAi - Technologies, Markets and Companies
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009
The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
RNAi/MicroRNA Market Report 2007
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery
U.S. RNAi Markets
RNAi Therapeutics 2008 Market Report
RNA Interference Markets
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
|
|
|
|
